The Journal of Innovative Therapeutics and Drug Care (JITDC) invites authors, researchers, clinicians, and academicians from around the world to submit original manuscripts for publication in our upcoming issues. We are committed to advancing knowledge and clinical practice in pharmacology, drug development, and patient-centered therapeutic care.
Scope of the Journal
We welcome high-quality contributions in the following (but not limited to) areas:
- Innovative drug discovery and development
- Clinical pharmacology and therapeutics
- Pharmacovigilance and medication safety
- Personalized and precision medicine approaches
- Pharmaceutical technology and novel drug delivery systems
- Patient care, pharmaceutical ethics, and medication adherence
- Regulatory science and drug approval processes
Submission Guidelines
- Manuscripts should be prepared according to the Instructions for Authors provided on our website.
- Submissions should be original and not under consideration for publication elsewhere.
- All submissions are subject to a rigorous peer review process to ensure the highest quality and integrity of the content.
- Accepted papers will be published in upcoming issues of the journal.
Submission Process
To submit your manuscript:
- Online Submission: Please submit your manuscript through our [online submission system].
- Review Timeframe: You will receive a response within 2-3 working days, and your paper will be reviewed within 8 days.
- Notification: You will receive acceptance or rejection notification within 22 days of submission.
Why Publish with JITDC?
- Rapid and rigorous double-blind peer review
- International editorial board of domain experts
- Open access for wider visibility and citation
- Indexed and discoverable globally
- No article processing charges (APCs) for inaugural issues
Contact Us
For queries related to submissions or the journal’s scope, please email us.
Join a growing community of researchers contributing to transformative innovations in drug care and therapeutics.
